List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
28 August 2015 | By Victoria White
Degenerating neurons in patients with Alzheimer's disease measurably responded to a gene therapy in which nerve growth factor was injected into their brains...
12 August 2015 | By Author: Katie Sadler, Digital Content Producer, Drug Target Review
Research carried out by University of California San Francisco (UCSF) has revealed ion channel blocking drugs could play a part in cancer therapy. The common class of channel blocking drugs, which are used to treat cardiac, neurological, and psychiatric disorders, could prove to be beneficial in cancer treatment according to…
4 August 2015 | By Victoria White
Researchers have used nanoparticles to breach the human airway mucus barrier of lung tissue - a finding that could lead to effective drug delivery systems...
31 July 2015 | By Victoria White
Researchers have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina...
28 July 2015 | By Victoria White
UMG and MRC Technology are to collaborate to develop a novel therapy for neurodegenerative diseases based on antibody targeting amyloid beta peptides 4-x...
28 July 2015 | By Victoria White
Regeneron and Sanofi have entered into a new global collaboration to discover, develop and commercialise new antibody cancer treatments in immuno-oncology...
24 July 2015 | By Victoria White
UCLA scientists have discovered a microRNA-214 inhibitor that has the ability to suppress the development of ulcerative colitis...
23 July 2015 | By Victoria White
Researchers have developed a test that analyses the sensitivity of tumours to radiation therapy and could lead the way for personalised therapies...
15 July 2015 | By Victoria White
Scientists have shown that gene therapy can give protection to the light-sensitive photoreceptor cells responsible for colour vision in retinitis pigmentosa...
13 July 2015 | By Oxford Global
With four months to go until the Next Generation Sequencing USA Congress and co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences are delighted to announce the release of the final agenda...
9 July 2015 | By Victoria White
Epizyme has amended and restated its agreement with Celgene to extend their research collaboration for at least three additional years...
8 July 2015 | By Oxford Global
Oxford Global Conferences are proud to present the Cell & Gene Therapy with our co-located 2nd Annual Stem Cell Congress is taking place on the 9th & 10th of November in London, UK...
2 July 2015 | By Victoria White
Biogen and AGTC have announced a broad collaboration and license agreement to develop gene therapies for multiple ophthalmic diseases...
30 June 2015 | By Victoria White
Celgene and Juno Therapeutics have entered into a global collaboration for the development and commercialisation of immunotherapies...
26 June 2015 | By Victoria White
Neuralstem has presented preclinical data on genetically modified HK532-IGF-1 stem cells in Alzheimer's disease at the ISSCR Annual Meeting...
